{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:07:04Z","timestamp":1772032024003,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.humimm.2026.111657","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T15:27:22Z","timestamp":1768922842000},"page":"111657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of anti-HLA antibodies pre- and post-renal transplantation in the Tunisian central region"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0995-2768","authenticated-orcid":false,"given":"Maha","family":"Changuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichrak","family":"Bannour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mourad","family":"Elghali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2678-4547","authenticated-orcid":false,"given":"Nouha Ben","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadhom","family":"Chouat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Jaafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7016-042X","authenticated-orcid":false,"given":"Wafa","family":"Aissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouna","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib","family":"Skhiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabil","family":"Sakly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111657_b0005","doi-asserted-by":"crossref","unstructured":"Park JY, Yang WJ, Doo SW, Park JJ, Gwon YN, Kim KM, et al. Long-term end-stage renal disease risks after living kidney donation: a systematic review and meta-analysis. BMC Nephrol. 30 mai 2023;24(1):152.","DOI":"10.1186\/s12882-023-03208-z"},{"issue":"5","key":"10.1016\/j.humimm.2026.111657_b0010","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0000000000000469","article-title":"Peak Panel Reactive Antibody, Cancer, Graft, and Patient Outcomes in Kidney Transplant Recipients","volume":"99","author":"Lim","year":"2015","journal-title":"Transplantation. Mai"},{"key":"10.1016\/j.humimm.2026.111657_b0015","doi-asserted-by":"crossref","unstructured":"Eleftheriadis T, Pissas G, Crespo M, Filippidis G, Antoniadis N, Liakopoulos V, et al. The effect of anti\u2011HLA class I antibodies on the immunological properties of human glomerular endothelial cells and their modification by mTOR inhibition or GCN2 kinase activation. Mol Med Rep. 12 mars 2021;23(5):355.","DOI":"10.3892\/mmr.2021.11994"},{"issue":"7","key":"10.1016\/j.humimm.2026.111657_b0020","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.transproceed.2019.01.195","article-title":"Frequency of Human Leukocyte Antigens and Donor specific Antibodies in Long-Term living Donor Kidney Transplantation","volume":"51","author":"Alagoz","year":"2019","journal-title":"Transplant Proc. Sept"},{"key":"10.1016\/j.humimm.2026.111657_b0025","doi-asserted-by":"crossref","unstructured":"De Sousa MV, Gon\u00e7alez AC, Zollner RDL, Mazzali M. Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients. Ann Transplant. 6 juill 2018;23:457\u201166.","DOI":"10.12659\/AOT.908491"},{"issue":"2","key":"10.1016\/j.humimm.2026.111657_b0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1590\/2175-8239-jbn-2018-0244","article-title":"Renal transplant patients with preformed anti-HLA antibodies: early biopsy findings and clinical outcomes","volume":"42","author":"Sousa","year":"2020","journal-title":"Braz J Nephrol. Juin"},{"key":"10.1016\/j.humimm.2026.111657_b0035","doi-asserted-by":"crossref","unstructured":"Saito PK, Yamakawa RH, Aparecida EP, Silva J\u00fanior WVD, Borelli SD. Evaluation of the Humoral Immune Response to Human Leukocyte Antigens in Brazilian Renal Transplant Candidates. Burdmann EA, \u00e9diteur. PLoS ONE. 13 juin 2014;9(6):e100270.","DOI":"10.1371\/journal.pone.0100270"},{"issue":"Suppl 1","key":"10.1016\/j.humimm.2026.111657_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.6002\/ect.MESOT2018.L41","article-title":"Anti-HLA Antibody: the Role of Epitopes in Organ Transplantation","volume":"17","author":"Argani","year":"2019","journal-title":"Exp Clin Transplant. Janv"},{"issue":"8","key":"10.1016\/j.humimm.2026.111657_b0045","article-title":"Impact of active antibody\u2010mediated rejection treatment on donor\u2010specific antibodies in pediatric kidney transplant recipients","volume":"23","author":"Kincaide","year":"2019","journal-title":"Pediatr Transplant. D\u00e9c"},{"issue":"1","key":"10.1016\/j.humimm.2026.111657_b0050","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12890-018-0606-8","article-title":"Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients","volume":"18","author":"Park","year":"2018","journal-title":"BMC Pulm Med. D\u00e9c"},{"issue":"4","key":"10.1016\/j.humimm.2026.111657_b0055","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1399-0039.2010.01466.x","article-title":"Nomenclature for factors of the HLA system, 2010","volume":"75","author":"Marsh","year":"2010","journal-title":"Tissue Antigens. Avr"},{"key":"10.1016\/j.humimm.2026.111657_b0060","doi-asserted-by":"crossref","unstructured":"Barker DJ, Maccari G, Georgiou X, Cooper MA, Flicek P, Robinson J, et al. The IPD-IMGT\/HLA Database. Nucleic Acids Res. 6 janv 2023;51(D1):D1053\u201160.","DOI":"10.1093\/nar\/gkac1011"},{"key":"10.1016\/j.humimm.2026.111657_b0065","article-title":"Influence of pretransplant class I and II non-donor-specific anti-HLA immunization on immunologic outcome and graft survival in kidney transplant recipients","volume":"63","author":"Staeck","year":"2020","journal-title":"Transpl Immunol. D\u00e9c"},{"issue":"2","key":"10.1016\/j.humimm.2026.111657_b0070","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1681\/ASN.2014090894","article-title":"Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates","volume":"27","author":"Sapir-Pichhadze","year":"2016","journal-title":"J Am Soc Nephrol. F\u00e9vr"},{"issue":"Suppl 3","key":"10.1016\/j.humimm.2026.111657_b0075","first-page":"53","article-title":"The Most Common HLA Alleles and Anti-HLA Antibodies to know for Virtual Cross-Match","volume":"14","author":"Ba\u015ft\u00fcrk","year":"2016","journal-title":"Exp Clin Transplant off J Middle East Soc Organ Transplant."},{"issue":"9","key":"10.1016\/j.humimm.2026.111657_b0080","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1111\/ajt.14709","article-title":"Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant","volume":"18","author":"Kamburova","year":"2018","journal-title":"Am J Transplant. Sept"},{"key":"10.1016\/j.humimm.2026.111657_b0085","doi-asserted-by":"crossref","unstructured":"Ravindranath MH, Ravindranath NM, Amato-Menker CJ. Luminex Multiplex Bead Assay Monitoring HLA IgG Antibodies in Sensitized Pre- and Post-transplant Patients: Clonality of the Detection Antibody Impacts Specificity and Sensitivity. Appl Sci. 12 juill 2021;11(14):6430.","DOI":"10.3390\/app11146430"},{"issue":"4\u20135","key":"10.1016\/j.humimm.2026.111657_b0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clinbiochem.2015.05.024","article-title":"Detection of alloantibody-mediated complement activation: a diagnostic advance in monitoring kidney transplant rejection?","volume":"49","author":"B\u00f6hmig","year":"2016","journal-title":"Clin Biochem. Mars"},{"key":"10.1016\/j.humimm.2026.111657_b0095","doi-asserted-by":"crossref","DOI":"10.5581\/1516-8484.20130043","article-title":"Red blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation","author":"Silva","year":"2013","journal-title":"Rev Bras Hematol E Hemoter [internet]."},{"key":"10.1016\/j.humimm.2026.111657_b0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.trim.2018.03.006","article-title":"Comparative analysis of two methods to detect donor-specific anti-HLA antibodies after kidney transplant","volume":"49","author":"Gil","year":"2018","journal-title":"Transpl Immunol. Ao\u00fbt"},{"issue":"3","key":"10.1016\/j.humimm.2026.111657_b0105","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/ijn.IJN_353_19","article-title":"Prevalence of Clinically significant anti-HLA Antibodies in Renal Transplant patients: Single-center Report from North India","volume":"31","author":"Chauhan","year":"2021","journal-title":"Indian J Nephrol."},{"issue":"12","key":"10.1016\/j.humimm.2026.111657_b0110","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1600-6135.2003.00273.x","article-title":"Pre-Transplant Assessment of Donor-Reactive, HLA-Specific Antibodies in Renal Transplantation: Contraindication vs","volume":"3","author":"Gebel","year":"2003","journal-title":"Risk. Am J Transplant. D\u00e9c"},{"key":"10.1016\/j.humimm.2026.111657_b0115","doi-asserted-by":"crossref","unstructured":"Tambur AR, Bray RA, Takemoto SK, Mancini M, Costanzo MR, Kobashigawa JA, et al. FLOW CYTOMETRIC DETECTION OF HLA-SPECIFIC ANTIBODIES AS A PREDICTOR OF HEART ALLOGRAFT REJECTION1: Transplantation. oct 2000;70(7):1055\u20119.","DOI":"10.1097\/00007890-200010150-00011"},{"issue":"2","key":"10.1016\/j.humimm.2026.111657_b0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.transproceed.2019.01.009","article-title":"Discrepant Antibody Testing results: which one to Believe?","volume":"51","author":"Al Attas","year":"2019","journal-title":"Transplant Proc. Mars"},{"issue":"9","key":"10.1016\/j.humimm.2026.111657_b0125","article-title":"Predictive value of mixed antigen screen beads in pre\u2010transplant assessment of HLA immunization in solid organ transplant recipients","volume":"34","author":"Snanoudj","year":"2020","journal-title":"Clin Transplant. Sept"},{"key":"10.1016\/j.humimm.2026.111657_b0130","doi-asserted-by":"crossref","unstructured":"Colombo MB, Haworth SE, Poli F, Nocco A, Puglisi G, Innocente A, et al. Luminex technology for anti\u2010HLA antibody screening: Evaluation of performance and of impact on laboratory routine. Cytometry B Clin Cytom. 15 nov 2007;72B(6):465\u201171.","DOI":"10.1002\/cyto.b.20353"},{"key":"10.1016\/j.humimm.2026.111657_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16982","article-title":"OPTN\/SRTR 2020 Annual Data Report: Kidney","volume":"22","author":"Lentine","year":"2022","journal-title":"Am J Transplant. Mars"},{"issue":"3","key":"10.1016\/j.humimm.2026.111657_b0140","first-page":"235","article-title":"Common predictors of adverse outcomes in adult deceased donor kidney transplant recipients with varying sensitization","volume":"11","author":"Santos","year":"2023","journal-title":"Am J Clin Exp Urol."},{"issue":"11","key":"10.1016\/j.humimm.2026.111657_b0145","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1681\/ASN.2019060594","article-title":"Pretransplant Kinetics of Anti-HLA Antibodies in patients on the Waiting list for Kidney Transplantation","volume":"30","author":"Togninalli","year":"2019","journal-title":"J Am Soc Nephrol JASN."},{"issue":"4","key":"10.1016\/j.humimm.2026.111657_b0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/tan.14704","article-title":"Prevalence and risk factors of antibodies to HLA according to different cut\u2010off values of mean fluorescence intensity in haploidentical allograft candidates: a prospective study of 3805 subjects","volume":"100","author":"Ma","year":"2022","journal-title":"HLA"},{"issue":"11","key":"10.1016\/j.humimm.2026.111657_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202451181","article-title":"Bead\u2010by\u2010bead normalization of single antigen assays: a necessary step for accurate detection of weak anti\u2010HLA antibodies","volume":"54","author":"Usureau","year":"2024","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111657_b0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00467-014-2868-6","article-title":"HLA sensitisation: can it be prevented?","volume":"30","author":"Rees","year":"2015","journal-title":"Pediatr Nephrol. Avr"},{"issue":"3","key":"10.1016\/j.humimm.2026.111657_b0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/jhg.2016.146","article-title":"The investigation of the origin of Southern Tunisians using HLA genes","volume":"62","author":"Hajjej","year":"2017","journal-title":"J Hum Genet. Mars"},{"key":"10.1016\/j.humimm.2026.111657_b0170","doi-asserted-by":"crossref","unstructured":"Ben Bnina A, Yessine A, El Bahri Y, Chouchene S, Ben Lazrek N, Mimouna M, et al. Contribution of HLA class I (A, B, C) and HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes in exploring ethnic origin of central Tunisians. BMC Med Genomics. 29 f\u00e9vr 2024;17(1):65.","DOI":"10.1186\/s12920-024-01821-x"},{"key":"10.1016\/j.humimm.2026.111657_b0175","article-title":"Unexpected frequencies of HLA antibody specificities present in sera of multitransfused patients","volume":"139\u201359","author":"Idica","year":"2006","journal-title":"Clin. Transpl."},{"issue":"5","key":"10.1016\/j.humimm.2026.111657_b0180","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ekir.2024.02.1394","article-title":"Utility of Routine Post Kidney Transplant Anti-HLA Antibody Screening","volume":"9","author":"Salhi","year":"2024","journal-title":"Kidney Int Rep. Mai"},{"issue":"5","key":"10.1016\/j.humimm.2026.111657_b0185","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1600-6143.2011.03961.x","article-title":"Donor-specific HLA Antibodies in a Cohort Comparing Everolimus with Cyclosporine after Kidney Transplantation","volume":"12","author":"Liefeldt","year":"2012","journal-title":"Am J Transplant. Mai"},{"key":"10.1016\/j.humimm.2026.111657_b0190","doi-asserted-by":"crossref","unstructured":"Lee H, Lee H, Eum SH, Ko EJ, Min JW, Oh EJ, et al. Impact of Low-Level Donor-Specific Anti-HLA Antibody on Posttransplant Clinical Outcomes in Kidney Transplant Recipients. Ann Lab Med. 1 juill 2023;43(4):364\u201174.","DOI":"10.3343\/alm.2023.43.4.364"},{"issue":"4","key":"10.1016\/j.humimm.2026.111657_b0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ajt.12651","article-title":"Prevalence, Incidence and Risk Factors for Donor-specific Anti-HLA Antibodies in Maintenance Liver Transplant patients","volume":"14","author":"Del Bello","year":"2014","journal-title":"Am J Transplant. Avr"},{"issue":"9","key":"10.1016\/j.humimm.2026.111657_b0200","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and Clinical Implications of Development of Donor-specific and Non\u2013Donor-specific HLA Antibodies after Kidney Transplantation","volume":"16","author":"Hourmant","year":"2005","journal-title":"J Am Soc Nephrol. Sept"},{"key":"10.1016\/j.humimm.2026.111657_b0205","article-title":"Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation","volume":"65","author":"Cioni","year":"2021","journal-title":"Transpl Immunol. Avr"},{"key":"10.1016\/j.humimm.2026.111657_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.703457","article-title":"Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients with Histological Antibody-Mediated rejection","volume":"12","author":"Crespo","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2026.111657_b0215","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in Transplantation: Assessment of risk (STAR) 2017 Working Group meeting Report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transplant. Juill"},{"issue":"5","key":"10.1016\/j.humimm.2026.111657_b0220","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and Clinical Pathologic Correlations of De Novo Donor-specific HLA Antibody Post Kidney Transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant. Mai"},{"key":"10.1016\/j.humimm.2026.111657_b0225","doi-asserted-by":"crossref","unstructured":"Lee PC, Terasaki PI, Takemoto SK, Lee PH, Hung CJ, Chen YL, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies: Transplantation. oct 2002;74(8):1192\u20114.","DOI":"10.1097\/00007890-200210270-00025"},{"key":"10.1016\/j.humimm.2026.111657_b0230","doi-asserted-by":"crossref","unstructured":"Loupy A, Lefaucheur C, Vernerey D, Prugger C, Van Huyen JPD, Mooney N, et al. Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival. N Engl J Med. 26 sept 2013;369(13):1215\u201126.","DOI":"10.1056\/NEJMoa1302506"},{"issue":"1","key":"10.1016\/j.humimm.2026.111657_b0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00467-008-1020-x","article-title":"Mechanism of cellular rejection in transplantation","volume":"25","author":"Ingulli","year":"2010","journal-title":"Pediatr Nephrol. Janv"},{"key":"10.1016\/j.humimm.2026.111657_b0240","doi-asserted-by":"crossref","unstructured":"Muji\u0107 Frani\u0107 A, Lili\u0107 M, Katalini\u0107 N, Glava\u0161-Obrovac L. Comprehensive Characterization of Anti-HLA and Non-HLA Antibodies in Patients on Kidney Transplant Waiting List and Evaluation of Their Impact on Alloimmunization Risk and Dialysis Treatment. Int J Mol Sci. 11 nov 2024;25(22):12103.","DOI":"10.3390\/ijms252212103"},{"key":"10.1016\/j.humimm.2026.111657_b0245","doi-asserted-by":"crossref","unstructured":"Alvares M, Anwar S, Hashmi SK, Zaman MB, Al Mahri A, Alvares C, et al. Development of a calculated panel reactive antibody calculator for the United Arab Emirates: a proof of concept study. Sci Rep. 25 mai 2023;13(1):8468.","DOI":"10.1038\/s41598-023-34860-y"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T13:36:25Z","timestamp":1772026585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0198885926000030"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111657","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of anti-HLA antibodies pre- and post-renal transplantation in the Tunisian central region","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111657"}}